EUVIMEDEUVIMED entdecken
Crossref

Liquid biopsy: a new diagnostic modality

Pranab Dey

The Applied Biology & Chemistry Journal · 2020

DOI: 10.52679/tabcj.2020.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Applied Biology & Chemistry Journal, 2020. Verfasst von Pranab Dey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liquid biopsy is the most promising technology in the modern days. It plays a significant role in the diagnosis, management and finding out the minimal residual disease in carcinoma. There are three components of the liquid biopsy: circulating tumour cells (CTC), cell-free DNA (cf-DNA), and exosomes. These components carry vital information, and with the help of sophisticated technology, one can extract a large amount of data from them. The detection of the tumour-specific gene mutation in the CTC or cf-DNA may guide the clinicians about the selection of the appropriate chemotherapeutic agents. The liquid biopsy is still not applied for routine clinical use, and more research is needed in this field. In this review, the techniques and applications of liquid biopsy have been discussed.

Zitieren

APA

Dey, P. (2020). Liquid biopsy: a new diagnostic modality. The Applied Biology & Chemistry Journal. https://doi.org/10.52679/tabcj.2020.0002

Vancouver

Dey P. Liquid biopsy: a new diagnostic modality. The Applied Biology & Chemistry Journal. 2020. doi:10.52679/tabcj.2020.0002

BibTeX
@article{Dey2020,
  author = {Dey, Pranab},
  title = {Liquid biopsy: a new diagnostic modality},
  journal = {The Applied Biology & Chemistry Journal},
  year = {2020},
  doi = {10.52679/tabcj.2020.0002}
}
Kostenlos starten →